Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2013

01-02-2013 | Breast Oncology

When is a Lymph Node Dissection a Lymph Node Dissection? The Number of Lymph Nodes Resected in Sentinel and Axillary Lymph Node Dissections

Authors: Windy Olaya, MD, Jasmine Wong, MD, Jan Wong, MD, John Morgan, DrPH, CPH, Kevork Kazanjian, MD, Sharon Lum, MD

Published in: Annals of Surgical Oncology | Issue 2/2013

Login to get access

Abstract

Purpose

We sought to compare the number of lymph nodes (LN) resected in axillary lymph node dissections (ALND) and sentinel lymph node dissections (SLND), and to assess the validity of registry reporting for axillary staging in breast cancer.

Methods

Women in the California Cancer Registry who underwent surgical axillary staging for T1/T2, M0 breast cancer between 2004 and 2008 were evaluated. The number of LN resected in patients reported as having SLND+ALND and ALND were assessed for compliance with 6 and 10 LN threshold definitions for ALND. The proportion of patients with ≤3 LN removed was assessed for patients receiving SLND only.

Results

Of 71,907 patients, 45.5 % had SLND, 24.0 %, SLND+ALND, and 30.5 %, ALND. The median number of LN resected with SLND cases was 2 (range 1–41); SLND+ALND, 9 (range 1–63); and ALND, 11 (range 1–81) (p < 0.0001). Of patients undergoing ALND, 56.7 % had ≥10 LN removed; 46.2 % of patients with SLND+ALND had ≥10 LN removed (p < 0.0001). Overall, 75.5 % of patients with ALND had ≥6 LN removed and 67.8 % of patients with SLND+ALND had ≥6 LN removed (p < 0.0001). Of those receiving only SLND, 83.4 % had ≤3 LN removed.

Conclusions

A significant proportion of patients did not meet the minimum LN count thresholds for full ALND or had excess LN removed in a SLND. Further investigation is required to determine whether absolute LN number or reported operative procedure and implied surgical technique better defines axillary staging in a registry database.
Literature
2.
go back to reference Soper NJ, Kaufman DB, eds. Northwestern handbook of surgical procedures. 2nd ed. Austin, TX: Landes Bioscience, 2011. Soper NJ, Kaufman DB, eds. Northwestern handbook of surgical procedures. 2nd ed. Austin, TX: Landes Bioscience, 2011.
3.
go back to reference Zollinger RMJ, Zollinger RM. Atlas of surgical operations. New York: MacGraw-Hill, 1993. Zollinger RMJ, Zollinger RM. Atlas of surgical operations. New York: MacGraw-Hill, 1993.
4.
go back to reference Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer. 1992;28A:1415–8.PubMedCrossRef Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer. 1992;28A:1415–8.PubMedCrossRef
5.
go back to reference Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 305:569–75. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 305:569–75.
6.
go back to reference Krag DN. Training manual for NSABP B-32. Pittsburgh, 1999. Krag DN. Training manual for NSABP B-32. Pittsburgh, 1999.
7.
go back to reference Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.PubMedCrossRef Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.PubMedCrossRef
8.
go back to reference Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–8.PubMedCrossRef Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–8.PubMedCrossRef
9.
go back to reference Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–9.PubMedCrossRef Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–9.PubMedCrossRef
10.
go back to reference McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–6.PubMed McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–6.PubMed
12.
go back to reference Chagpar AB, Scoggins CR, Martin RC 2nd, et al. Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J. 2007;13:233–7.PubMedCrossRef Chagpar AB, Scoggins CR, Martin RC 2nd, et al. Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J. 2007;13:233–7.PubMedCrossRef
13.
go back to reference Olaya W, Wong J, Morgan JW, et al. Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer. Ann Surg Oncol. 2010;17(3):297–302.PubMedCrossRef Olaya W, Wong J, Morgan JW, et al. Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer. Ann Surg Oncol. 2010;17(3):297–302.PubMedCrossRef
14.
go back to reference Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–8.PubMedCrossRef Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–8.PubMedCrossRef
15.
go back to reference Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008;113:30–7.PubMedCrossRef Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008;113:30–7.PubMedCrossRef
16.
go back to reference Zakaria S, Degnim AC, Kleer CG, et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007;96:554–9.PubMedCrossRef Zakaria S, Degnim AC, Kleer CG, et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007;96:554–9.PubMedCrossRef
17.
go back to reference Cil T, Hauspy J, Kahn H, et al. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients. Ann Surg Oncol. 2008;15:3361–8.PubMedCrossRef Cil T, Hauspy J, Kahn H, et al. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients. Ann Surg Oncol. 2008;15:3361–8.PubMedCrossRef
18.
go back to reference Posther KE, McCall LM, Blumencranz PW, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242:593–9.PubMed Posther KE, McCall LM, Blumencranz PW, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242:593–9.PubMed
Metadata
Title
When is a Lymph Node Dissection a Lymph Node Dissection? The Number of Lymph Nodes Resected in Sentinel and Axillary Lymph Node Dissections
Authors
Windy Olaya, MD
Jasmine Wong, MD
Jan Wong, MD
John Morgan, DrPH, CPH
Kevork Kazanjian, MD
Sharon Lum, MD
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2642-6

Other articles of this Issue 2/2013

Annals of Surgical Oncology 2/2013 Go to the issue